GlobeImmune, Inc.
(Other OTC/NBB : GBIM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -10.01%43.510.0%$294.92m
HZNPHorizon Therapeutics Plc -3.86%99.735.4%$183.13m
VRXValeant Pharmaceuticals International, Inc. -0.17%23.4214.1%$137.81m
CTLTCatalent, Inc. -5.03%121.242.0%$134.31m
ICLRICON plc 0.26%273.762.8%$114.35m
UTHRUnited Therapeutics Corp. -2.86%183.8813.9%$76.55m
JAZZJazz Pharmaceuticals Plc -0.91%121.582.1%$74.90m
BHCBausch Health Cos., Inc. -0.26%23.400.0%$60.91m
PRGOPerrigo Co. Plc -0.13%35.796.9%$60.42m
ARGXargenx SE -2.68%287.000.0%$55.28m
CPIXCumberland Pharmaceuticals, Inc. 3.32%4.360.6%$49.49m
ENDPEndo International Plc -6.35%4.958.5%$43.71m
IRWDIronwood Pharmaceuticals, Inc. -1.44%10.959.5%$26.02m
PCRXPacira Biosciences, Inc. -0.87%53.289.8%$25.09m
QLGNQualigen Therapeutics, Inc. -7.58%1.220.0%$23.56m

Company Profile

GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.